Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=117"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=117

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT02235545-sae",
        "title": "Right Ventricle Lead-Related Complications vs Summary of System and/or Procedure Related Complications Not Related to the RV Lead.: serious adverse events",
        "summary": "58 of 1735 against 134 of 1735; risk difference -4.4 points, 95% interval -5.9 to -2.9; NCT02235545, Optisure Lead Post Approval Study",
        "record": "/library/comparisons/NCT02235545-sae",
        "nct_id": "NCT02235545",
        "kind": "serious-adverse-events",
        "participants": 3470,
        "risk_difference": {
          "value": -0.04380403458213256,
          "lower": -0.05925255409388122,
          "upper": -0.028746056541267884
        },
        "group_1": "58 of 1,735",
        "group_2": "134 of 1,735",
        "difference": "-4.4 points",
        "interval": "-5.9 to -2.9",
        "trial_title": "Optisure Lead Post Approval Study"
      },
      {
        "id": "NCT00153101-fea57cf6",
        "title": "Telmisartan (TRANSCEND) vs Placebo (TRANSCEND): TRANSCEND. Newly Diagnosed Diabetes",
        "summary": "124 of 1710 against 165 of 1751; risk difference -2.2 points, 95% interval -4.0 to -0.3; NCT00153101, Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.",
        "record": "/library/comparisons/NCT00153101-fea57cf6",
        "nct_id": "NCT00153101",
        "kind": "outcome",
        "participants": 3461,
        "risk_difference": {
          "value": -0.02171724762124233,
          "lower": -0.04020344455886146,
          "upper": -0.003270775442302771
        },
        "group_1": "124 of 1,710",
        "group_2": "165 of 1,751",
        "difference": "-2.2 points",
        "interval": "-4.0 to -0.3",
        "trial_title": "Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo."
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=118",
  "request_id": "JjE_DTKAAVmhR2p-"
}